Prezzo di Moon AppAPP

nice app

.@ParticleNtwrk just dropped its full token utility roadmap with a gradual & compounding model. Currently $PARTI powers Particle Chain, settling all UA activity (capturing both chain + infra utility): As Particle ecosystem scales with adoption ➝ organic demand for $PARTI grows This forms a strong value-accrual base imo as the landscape matures. Once self-sustaining, app-layer utility (IDOs, auctions, etc.) compounds it further which will drive steady & sustainable growth.

How many of you have pretended to take a bathroom break just to check your CoinGecko app?

Echos, the artificial intelligence platform for agentic tokens, is shutting down. On March 27, the AI agent platform, developed by Cosmos based liquid staking platform Stride, notified its community that operations will cease on May 1, 2025. Echos, which launched in beta in November 2024, cited low adoption as the main reason for its closure. According to a notice posted on X, the experiment failed to gain meaningful traction, reflecting a broader slowdown in the crypto AI agent space. “Echos was always an experiment. Unfortunately, Echos has seen little adoption. Also, the overall AI agents market has contracted significantly,” the team stated. Echos is a Stride app built on Celestia, designed as a rollup. At launch, the Stride team envisioned Echos’ AI and memecoin focus as a potential disruptor to the future of decentralized finance . The plan was to evolve Echos from an experimental product into a full rollup ecosystem supporting various use cases within Stride’s liquid staking network. However, a lack of user traction has brought those ambitions to an end. The Echos team has urged all users to withdraw their funds before the platform shuts down permanently on May 1. According to Stride, Echos drew inspiration from Terminal of Truths, the AI agent that saw the memecoin Goateus Maximus ( GOAT ) explode in the summer of 2024. It went on to hit $1 billion in market cap . Terminal of Truths, a large language model platform backed by Marc Andreessen of Andreessen Horowitz, gained notoriety after shilling the GOAT token on X—an action that sent the memecoin soaring. Stride’s vision for Echos was to create a similar AI experience, allowing anyone to launch their own Echo using just a crypto wallet and X account. While Echos failed to go beyond the first phase of its development, the AI agent sector has since seen several notable projects. Some of the top trending ones include Virtuals Protocol, ai16z, Freysa AI and Delysium.

XRP Healthcare, a pioneer in AI-based healthcare and mergers & acquisitions (M&A), has accelerated its initial public offering (IPO) to the third quarter of this year. Initially scheduled for 2027, the company will now go public on a Canadian stock exchange to fuel its global growth. Chairman Whitney Lynn, who has worked on more than $10 billion in M&A deals, confirmed the action. “The IPO process has been in motion for several months, and we expect to be publicly listed before September,” he said. As part of its rapid growth strategy, XRP Healthcare recently acquired Pharma Ville, a pharmacy chain in Uganda, as reported earlier this month. This strengthened its supply chain and securing a foothold in Africa’s $259 billion healthcare market. “Pharma Ville isn’t just an acquisition—it’s a foundation for large-scale expansion,” said Laban Roomes, Chief Operating Officer. He added, We’re securing key distribution channels and preparing for the next phase of growth. With private institutions delivering 50% of the healthcare services across Africa, XRP Healthcare hopes to consolidate and modernize the industry. “Africa’s healthcare system is highly fragmented,” CEO Kain Roomes said in a press release . He added, “The IPO provides capital to strengthen access and quality while driving regional expansion.” The firm already has plans for expansion into Rwanda and Kenya by building on regulatory foundations laid out in Uganda. For further context, XRP Healthcare’s IPO is advised by ARC Group, an international capital markets advisory company. CEO Abraham Cinta highlighted the effect of the listing: “Becoming a public company could scale their business exponentially, perhaps by a factor of 10 or even 100.” Charles Chong, EMEA Capital Markets Vice President at ARC Group, continued, “Listing in Canada is just the first step. A U.S. listing is planned within five years to boost global investor exposure.” The firm is making investments in AI-powered solutions to enhance healthcare accessibility. Its XRPH AI App, which can be downloaded on the Google Play Store and Apple App Store, offers multilingual AI-powered medical information. New functionalities encompass AI-enhanced image interpretation for the diagnosis of visible symptoms and a forthcoming “Doctor Search & Connect” capability for immediate consultation with certified professionals. XRP Healthcare also gained an exclusive partnership with Isansys Lifecare to roll out the Patient Status Engine (PSE) in Africa. This allows wireless AI-powered monitoring of health to aid home care and decongest hospitals. Furthermore, in an effort to enhance its scope, XRP Healthcare has collaborated with prominent pharmaceutical providers, such as: Having trademarked its name within the UK, EU, UAE, and Uganda, XRP Healthcare is carving out a role for itself in the healthcare revolution by way of AI.